Cargando…

A Possible Anticancer Agent, Type III Interferon, Activates Cell Death Pathways and Produces Antitumor Effects

Recently identified interleukin-28 and -29 belong to a novel type III interferon (IFN) family, which could have distinct biological properties from type I and II IFNs. Type I IFNs, IFN-α/β, have been clinically applied for treating a certain kind of malignancies for over 30 years, but a wide range o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tagawa, Masatoshi, Kawamura, Kiyoko, Li, Quanhai, Tada, Yuji, Hiroshima, Kenzo, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195555/ https://www.ncbi.nlm.nih.gov/pubmed/22013482 http://dx.doi.org/10.1155/2011/479013

Ejemplares similares

Interferon-β Produces Synergistic Combinatory Anti-Tumor Effects with Cisplatin or Pemetrexed on Mesothelioma Cells
por: Li, Quanhai, et al.
Publicado: (2013)

Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured
por: Suzuki, Takeo, et al.
Publicado: (2014)

A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine
por: Tada, Yuji, et al.
Publicado: (2013)

Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels
por: Okamoto, Shinya, et al.
Publicado: (2013)

Gene medicine for cancer treatment: Commercially available medicine and accumulated clinical data in China
por: Ma, Guangyu, et al.
Publicado: (2009)

Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
por: Jiang, Yuanyuan, et al.
Publicado: (2016)

Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression
por: Yang, Shan, et al.
Publicado: (2015)

Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes
por: Yamauchi, Suguru, et al.
Publicado: (2017)

Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
por: Zhong, Boya, et al.
Publicado: (2015)

Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways
por: Shimazu, Kengo, et al.
Publicado: (2017)

Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
por: Ak, Guntulu, et al.
Publicado: (2017)

A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene
por: Tada, Yuji, et al.
Publicado: (2015)

An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol
por: Tada, Yuji, et al.
Publicado: (2016)

Diffuse pleural thickening and thoracic contraction: An indistinguishable case from malignant pleural mesothelioma
por: Tada, Yuji, et al.
Publicado: (2020)

An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expression
por: Nguyen, Thao Thi Thanh, et al.
Publicado: (2021)

Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma
por: Ma, G, et al.
Publicado: (2010)

An image cytometric technique is a concise method to detect adenoviruses and host cell proteins and to monitor the infection and cellular responses induced
por: Morinaga, Takao, et al.
Publicado: (2017)

Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity
por: Chai, Kuan, et al.
Publicado: (2018)

Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects
por: Li, Q, et al.
Publicado: (2011)

Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
por: Masunaga, Atsuko, et al.
Publicado: (2018)

Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions
por: Okamoto, S, et al.
Publicado: (2014)

Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells
por: Qin, Yiyang, et al.
Publicado: (2017)

Anticancer and Interferon Agents: Synthesis and Properties - Drugs and Parmacutical Sciences - Vol. 24
por: Fox, B.W.
Publicado: (1985)

Interferon related pericarditis: Review
por: Nishio, Kazuaki, et al.
Publicado: (2017)

Cyclometalated Ir(III) Complexes as Lysosome-Targeted Photodynamic Anticancer Agents
por: Zhu, Jiayi, et al.
Publicado: (2023)

Properties of realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent
por: Chen, Peng, et al.
Publicado: (2017)

A Screening Strategy for Metal Antitumor Agents as Exemplified by Gold(III) Complexes
por: Fricker, Simon P.
Publicado: (1999)

Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
por: Wang, Fang-Xin, et al.
Publicado: (2016)

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020)

Cysteine-modifying agents: a possible approach for effective anticancer and antiviral drugs.
por: Casini, Angela, et al.
Publicado: (2002)

Molecular Hydrogen as a Novel Antitumor Agent: Possible Mechanisms Underlying Gene Expression
por: Hirano, Shin-ichi, et al.
Publicado: (2021)

The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry
por: Zhao, Hongjuan, et al.
Publicado: (2017)

Structure-Activity Relationship for Fe(III)-Salen-Like Complexes as Potent Anticancer Agents
por: Ghanbari, Zahra, et al.
Publicado: (2014)

Multifunctional Heterometallic Ir(III)−Au(I) Probes as Promising Anticancer and Antiangiogenic Agents
por: Redrado, Marta, et al.
Publicado: (2021)

Bioactive Salen-type Schiff Base Transition Metal Complexes as Possible Anticancer Agents
por: Damercheli, Maryam, et al.
Publicado: (2019)

Neutrophils and interferon-α-producing cells: who produces interferon in lupus?
por: Decker, Patrice
Publicado: (2011)

Recruiting interferon producers
por: Johnston, Nicole
Publicado: (2005)

Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent.
por: Suzuki, F., et al.
Publicado: (1986)

Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
por: Crespo-Ortiz, Maria P., et al.
Publicado: (2012)

Flavonoids as Anticancer Agents
por: Kopustinskiene, Dalia M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2lph97pnrb7l2sdnj5qrnt62pe